What Is ADHD? A Difference in How Your Brain Controls Attention, Not a Lack of It
Clinically reviewed by Elizabeth Lokenauth, PA-C, CAQ-Psy
Reviewed November 5, 2026 · Last updated November 5, 2026
Key Takeaways
- ADHD is a developmental condition marked by inattention, hyperactivity, and impulsivity that are more severe, frequent, and persistent than everyday lapses and show up in at least two areas of life.
- Genes drive most ADHD risk. Twin and family studies put heritability at about 74%, and environmental factors such as lead exposure or alcohol and tobacco use during pregnancy add to it.
- ADHD is common in adults. In a 2023 CDC survey, an estimated 15.5 million U.S. adults reported a current diagnosis, and 55.9% were diagnosed at age 18 or older.
- Most people don't fully outgrow ADHD. In a 16-year follow-up, only 9.1% of children with ADHD reached sustained recovery, while 63.8% moved in and out of remission.
- Stimulants and atomoxetine have the strongest short-term evidence in adults. Therapies such as CBT also help, and every option carries trade-offs worth weighing with a clinician.
You can lose an entire afternoon to something that grabs you, then stall for a week on a form that would take ten minutes. People may have called that laziness or a lack of willpower. There’s a better explanation, and it starts with how your brain develops.
Your prefrontal cortex, the region behind your forehead that steers attention and plans what you do next, keeps maturing through childhood and adolescence. In an NIMH imaging study of 446 children, half the cortex reached peak thickness by a median age of 10.5 in kids with ADHD, compared with 7.5 in kids without it, and the delay was most prominent in prefrontal regions that control attention. Understanding ADHD takes that kind of precision, because the difference lies in how your brain controls attention and action.
The established approach is well defined. NIMH’s adult ADHD guide describes a persistent pattern of inattention, hyperactivity, or impulsivity that starts before age 12 and makes it hard to function in at least two areas of life, and it lists medication and cognitive behavioral therapy as the most common adult treatments. In a 2018 network meta-analysis of 133 double-blind trials, amphetamines, methylphenidate, and atomoxetine each reduced core symptoms in adults more than placebo. The results are real, and the science is well established.
But a symptom checklist describes only the surface of a condition that research now traces to genes and brain development, and at Siggy we think you deserve the full explanation before anyone hands you a label.
That explanation starts with heredity. Twin, family, and adoption studies put ADHD’s heritability at about 74%, according to a Molecular Psychiatry review, which means genetic differences account for most of the variation in ADHD risk between people. It reframes a lifetime of struggling as something with a biological basis, and that reframing rests on genetics and neuroscience.
What This Page Covers
- What Is ADHD, in Plain Terms?
- What Are the Three Types of ADHD?
- What Causes ADHD?
- How Common Is ADHD in Adults?
- Does ADHD Go Away With Age?
- How Is ADHD Diagnosed?
- How Is ADHD Treated?
- How Siggy Fits In
- See Your Whole Pattern Before You Decide What Comes Next
What Is ADHD, in Plain Terms?
ADHD, short for attention-deficit/hyperactivity disorder, is a developmental condition. That means it shapes how your brain grows and works, starting in childhood. NIMH groups its symptoms into three kinds:
- Inattention: trouble paying attention, staying on task, or staying organized
- Hyperactivity: excess activity or restlessness, even at the wrong times, and trouble with quiet activities
- Impulsivity: acting without thinking, or trouble with self-control
Everyone has these moments. In ADHD, NIMH explains, they’re more severe, frequent, and persistent, they show up across situations, and they last at least 6 months. In adults, that can mean work problems, strained relationships, missed appointments, or unfinished projects.
ADHD often travels with other conditions. NIMH notes that it often co-occurs with other mental health conditions and can make them harder to treat, and that sleep problems affect up to 70% of adults with ADHD.
What Are the Three Types of ADHD?
Clinicians describe ADHD by which symptoms dominate. CDC’s ADHD overview lists three presentations, based on which symptoms are strongest at the time of diagnosis:
- Predominantly inattentive presentation
- Predominantly hyperactive-impulsive presentation
- Combined presentation, with both kinds of symptoms
The word presentation is deliberate. CDC notes that symptoms can change over time and may increase as the demands of daily life grow. NIMH adds that inattention often persists with age while hyperactivity and impulsivity tend to decline, so a child diagnosed with the combined type may mostly have inattentive symptoms as an adult.
Quieter symptoms are easier to overlook. NIMH notes that symptoms in girls and women are especially likely to have been missed in childhood. Our post on ADD vs. ADHD explains where the older name for the inattentive type came from.
What Causes ADHD?
ADHD has no single cause. An international consensus statement approved by 80 authors from 27 countries concluded that multiple genetic and environmental risk factors accumulate in different combinations to cause ADHD, leading to subtle changes in several brain networks.
Genes carry most of the weight. The Molecular Psychiatry review notes that about a third of ADHD’s heritability comes from many common genetic variants, each with a small effect, and that rare deletions or duplications of DNA account for part of the rest. There’s no single ADHD gene.
Environment adds to that risk. CDC lists possible risk factors including:
- Exposure to lead or other environmental risks during pregnancy or early childhood
- Alcohol and tobacco use during pregnancy, and other pregnancy-related factors
- Child health conditions, including head injuries
Some popular explanations don’t hold up. The consensus statement cites a meta-analysis of seven studies with more than 25,000 participants that found no link between sugar consumption and ADHD in young people.
How Common Is ADHD in Adults?
ADHD is more common in adults than many assume. The consensus statement estimates that it affects 5.9% of young people and 2.8% of adults worldwide.
In the U.S., a 2023 CDC survey estimated that 15.5 million adults, or 6.0%, had a current ADHD diagnosis. Of those, 55.9% were diagnosed at age 18 or older, and about a third weren’t receiving any ADHD treatment. The survey relied on self-report and had low response rates, so treat the exact figures as estimates.
The two numbers measure different things. The worldwide figure counts adults who meet diagnostic criteria in research studies, while the CDC figure counts U.S. adults who say a clinician diagnosed them.
So why do so many people reach adulthood undiagnosed? NIMH points to teachers and parents who didn’t recognize the signs, supportive environments that helped people cope, and milder symptoms that only became a problem under adult demands. Our guide Do I Have ADHD? walks through the adult signs that get missed.
Does ADHD Go Away With Age?
For most people, ADHD doesn’t fully go away. The often-quoted estimate is that about half of children outgrow it by adulthood, and the Multimodal Treatment Study of ADHD challenged that idea. In a 16-year follow-up of 558 children with ADHD, about 30% reached full remission at some point, but 60% of them saw symptoms return. Only 9.1% stayed in sustained recovery, 10.8% had steadily persistent ADHD, and 63.8% moved in and out of remission over time.
The symptoms themselves shift. In adults, NIMH lists signs like disorganization, procrastination, poor time management, forgetting daily tasks, and feelings of restlessness. Our post on whether ADHD gets worse with age covers midlife changes in more detail.
How Is ADHD Diagnosed?
There’s no single test. CDC notes that deciding whether someone has ADHD is a process with several steps, partly because anxiety, depression, sleep problems, and some learning disabilities can cause similar symptoms.
For adults, NIMH describes the core requirements: symptoms that started before age 12, at least five symptoms of inattention or hyperactivity and impulsivity for anyone over 16, problems in at least two areas of life, and a pattern lasting at least 6 months. Because childhood history matters, a clinician may talk with a partner or family member, look at school records, and use interviews, rating scales, and questions about your mood and medical history.
One myth deserves a direct answer. NIMH’s medication guide notes that prescription stimulants improve alertness and focus for most people, regardless of diagnosis. Feeling sharper on a stimulant isn’t evidence of ADHD on its own. Our guide on how to get an ADHD diagnosis explains who can evaluate you and what to bring.
How Is ADHD Treated?
Treatment can reduce symptoms and improve functioning. NIMH notes that effective treatment often combines elements such as medication and therapy, and that some people try several options before finding the right one. This table summarizes a 2025 network meta-analysis of 113 randomized trials in 14,887 adults, which its authors describe as the most complete synthesis of the evidence so far.
| Option | Examples | What Adult Trials Show | Key Trade-Offs |
|---|---|---|---|
| Stimulants | Amphetamines, methylphenidate | Beat placebo on self and clinician ratings | Can raise heart rate and blood pressure |
| Non-stimulant | Atomoxetine | Beat placebo on self and clinician ratings | More dropouts than placebo |
| Psychological therapies | CBT, psychoeducation, mindfulness | Beat placebo on clinician ratings only | Results varied by who rated them |
NIMH’s medication guide notes the heart rate and blood pressure effects, and the 2018 meta-analysis found amphetamines had the largest effect in adults, favoring them as a first choice for short-term treatment. The 2025 analysis also found that ADHD medications didn’t improve quality of life in trials and that long-term evidence is thin. Our explainer on how Strattera works covers the non-stimulant route.
Long-term trade-offs cut both ways. In a Swedish national cohort of 148,578 people with ADHD, starting medication within 3 months of diagnosis was linked to a 21% lower rate of death from any cause over 2 years, especially deaths from unnatural causes such as injuries, suicide, and accidental poisonings. On the other side, a Swedish case-control study found that each additional year of ADHD medication use was associated with a 4% higher risk of cardiovascular disease, especially high blood pressure. Both studies were observational, so they show associations rather than proof, and the cardiovascular study’s authors recommend monitoring heart health throughout treatment.
How Siggy Fits In
Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including ADHD. That matters here, because anxiety and depression can cause symptoms that look like ADHD, and sorting out what’s driving your symptoms is the first step to treating them.
What Siggy can do is help you put your history into words. The anonymous intake needs no name, email, or account, and you can describe your focus, sleep, mood, and childhood patterns in your own language. You’ll get a downloadable summary you can share with any clinician, so you don’t have to retell your story from scratch. A licensed prescriber reviews your full intake before making a diagnosis or prescribing anything.
Siggy isn’t an emergency service. If you’re in crisis or thinking about suicide, call 911 or call or text 988. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.
See Your Whole Pattern Before You Decide What Comes Next
ADHD is a common, highly heritable difference in how the brain develops and controls attention, and for most people it doesn’t simply disappear with age. Effective treatments exist, and each one carries trade-offs worth weighing with a clinician who knows your full history. For a closer look at how it shows up day to day, read our guide to ADHD symptoms in adults. Start your anonymous intake and describe your focus, sleep, and mood in your own words. It’s free, a real doctor reviews every clinical decision, and the summary is yours to share with whoever does your evaluation.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What is ADHD in simple terms?
ADHD is a developmental condition that makes it harder to control attention, activity, and impulses. NIMH describes three kinds of symptoms: inattention, hyperactivity, and impulsivity. In ADHD, these are more severe, frequent, and persistent than everyday lapses, start before age 12, and cause problems in at least two areas of life.
What causes ADHD?
ADHD has no single cause, but genes play the largest role. Twin and family studies estimate its heritability at about 74%. CDC lists possible environmental risk factors, including lead exposure, alcohol and tobacco use during pregnancy, and head injuries. A meta-analysis of more than 25,000 young people found no link between sugar and ADHD.
What are the three types of ADHD?
The three types are predominantly inattentive, predominantly hyperactive-impulsive, and combined. Clinicians assign them based on which symptoms are strongest at the time of diagnosis, and CDC notes that the way symptoms present can change over time.
Can you outgrow ADHD?
Most people don't fully outgrow ADHD. In the Multimodal Treatment Study of ADHD, about 30% of children reached full remission at some point, but 60% of them saw symptoms return, and only 9.1% stayed in sustained recovery into young adulthood. Hyperactivity tends to fade with age, while inattention often persists.
How common is ADHD in adults?
ADHD is common in adults. An international consensus statement estimates it affects 2.8% of adults worldwide. In a 2023 CDC survey, an estimated 15.5 million U.S. adults, or 6.0%, reported a current ADHD diagnosis, and more than half were diagnosed at age 18 or older.
If a stimulant helps me focus, does that mean I have ADHD?
A stimulant helping you focus isn't evidence of ADHD on its own. NIMH notes that prescription stimulants improve alertness and focus for most people, regardless of diagnosis. An ADHD diagnosis rests on a long-standing pattern of symptoms that began before age 12 and affects at least two areas of life.
What is the most effective treatment for adult ADHD?
Medication has the strongest short-term evidence for adult ADHD. A 2025 network meta-analysis of 113 adult trials found that stimulants and atomoxetine were the only treatments that reduced core symptoms on both self-reported and clinician-rated scales. Therapies such as CBT improved clinician-rated symptoms, and many adults combine medication with therapy.
Sources
- Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences. 2007;104(49):19649-19654. doi:10.1073/pnas.0707741104
- National Institute of Mental Health. ADHD in Adults: 4 Things to Know. NIH Publication No. 24-MH-3573. 2024. nimh.nih.gov
- Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. doi:10.1016/S2215-0366(18)30269-4
- Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry. 2019;24(4):562-575. doi:10.1038/s41380-018-0070-0
- Centers for Disease Control and Prevention. About ADHD: ADHD in Children. Reviewed July 30, 2026. cdc.gov
- Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818. doi:10.1016/j.neubiorev.2021.01.022
- Staley BS, Robinson LR, Claussen AH, et al. Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults: National Center for Health Statistics Rapid Surveys System, United States, October-November 2023. MMWR Morbidity and Mortality Weekly Report. 2024;73(40):890-895. doi:10.15585/mmwr.mm7340a1
- Sibley MH, Arnold LE, Swanson JM, et al. Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry. 2022;179(2):142-151. doi:10.1176/appi.ajp.2021.21010032
- National Institute of Mental Health. Mental Health Medications. nimh.nih.gov
- Ostinelli EG, Schulze M, Zangani C, et al. Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. Lancet Psychiatry. 2025;12(1):32-43. doi:10.1016/S2215-0366(24)00360-2
- Li L, Zhu N, Zhang L, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. 2024;331(10):850-860. doi:10.1001/jama.2024.0851
- Zhang L, Li L, Andell P, et al. Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry. 2024;81(2):178-187. doi:10.1001/jamapsychiatry.2023.4294